An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer
- 16 June 2021
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 81 (16), 4230-4241
- https://doi.org/10.1158/0008-5472.can-20-3625
Abstract
AIB1Δ4 is an N-terminally truncated isoform of the oncogene Amplified In Breast Cancer 1 (AIB1) with increased expression in high-grade human ductal carcinoma in situ (DCIS). However, the role of AIB1Δ4 in DCIS malignant progression has not been defined. Here we CRISPR-engineered RNA splice junctions to produce normal and early stage DCIS breast epithelial cells that expressed only AIB1Δ4. These cells showed enhanced motility and invasion in 3D cell culture. In zebrafish, AIB1Δ4-expressing cells enabled invasion of parental cells when present in a mixed population. In mouse xenografts, a subpopulation of AIB1Δ4 cells mixed with parental cells enhanced tumor growth, recurrence, and lung metastasis. AIB1Δ4 ChIP-seq revealed enhanced binding to regions including peroxisome proliferator activated receptor (PPAR) and glucocorticoid receptor (GR) genomic recognition sites. H3K27ac and H3K4me1 genomic engagement patterns revealed selective activation of breast cancer-specific enhancer sites by AIB1Δ4. AIB1Δ4 cells displayed upregulated inflammatory response genes and downregulated PPAR signaling gene expression patterns. In the presence of AIB1Δ4 enabler cells, parental cells increased NFκB and WNT signaling. Cellular crosstalk was inhibited by the PPARγ agonist efatutazone but was enhanced by treatment with the GR agonist dexamethasone. In conclusion, expression of the AIB1Δ4-selective cistrome in a small subpopulation of cells triggers an "enabler" phenotype hallmarked by an invasive transcriptional program and collective malignant progression in a heterogeneous tumor population.Other Versions
Funding Information
- NCI
- NCI
- NIH
- NIH (R01CA205632)
- NCI (T32 CA009686)
This publication has 57 references indexed in Scilit:
- Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancerThe EMBO Journal, 2011
- Role of the Nuclear Receptor Coactivator AIB1-Δ4 Splice Variant in the Control of Gene TranscriptionOnline Journal of Public Health Informatics, 2011
- Steroid Receptor Coactivator (SRC) Family: Masters of Systems BiologyOnline Journal of Public Health Informatics, 2010
- Histone H3K27ac separates active from poised enhancers and predicts developmental stateProceedings of the National Academy of Sciences of the United States of America, 2010
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin SignalingCell, 2009
- The role and regulation of the nuclear receptor co-activator AIB1 in breast cancerBreast Cancer Research and Treatment, 2009
- Molecular restoration of archived transcriptional profiles by complementary-template reverse-transcription (CT-RT)Nucleic Acids Research, 2007
- Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genomeNature Genetics, 2007
- AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian CancerScience, 1997